
VMD states excipient may pose a risk to humans
The Veterinary Medicines Directorate (VMD) has suspended veterinary medicines containing diethanolamine (DEA) over concerns the excipient may pose a risk to humans.
In a press release, the VMD said it had made the decision 'in light of scientific opinion of the Committee for Medicinal Products for Veterinary Use (CVMP)'. It states there may be a risk to humans from consuming food from animals treated with products containing DEA.
The affected products are as follows:
| Product | VM Number | MAH |
| Allevinix 50 mg/ml Solution for Injection for Cattle, Pigs and Horses | 15052/4144 | Ceva Animal Health Ltd |
| Cronyxin Injection, 5% w/v Solution for Injection |
12597/4014 | Cross Vetpharm Group Ltd |
| Dugnixon 50 mg/ml Solution for Injection for Cattle, Pigs and Horses | 36167/4005 | Global Vet Health S.L. |
| Finadyne 50 mg/ml Solution for Injection | 01708/4582 | Intervet UK Ltd |
| Flunixin 50 mg/ml Solution for Injection for Cattle, Horses and Pigs | 02000/4170 | Norbrook Laboratories Limited |
| Meflosyl 5% Solution for Injection | 42058/4085 | Zoetis UK Limited |
| Norixin 5% Solution for Injection | 02000/4137 | Norbrook Laboratories Limited |
| Pyroflam 50 mg/ml Solution for Injection for Cattle, Horses and Pigs | 02000/4253 |
Norbrook Laboratories Limited |
| Tribrissen 48% Suspension for Injection | 01708/4593 | Intervet UK Ltd |



FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.